¼¼°èÀÇ ´ÜÀÏ¿°±â´ÙÇü¼º(SNP) Áö³ëŸÀÌÇÎ ¹× ºÐ¼® ½ÃÀå º¸°í¼­(2025³â)
SNP Genotyping And Analysis Global Market Report 2025
»óǰÄÚµå : 1760716
¸®¼­Ä¡»ç : The Business Research Company
¹ßÇàÀÏ : On Demand Report
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 175 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 4,490 £Ü 6,235,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 6,490 £Ü 9,013,000
PDF (Site License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ »ç¾÷ÀåÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 8,490 £Ü 11,790,000
PDF (Enterprise License) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμ⠰¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


¤± Add-on °¡´É: °í°´ÀÇ ¿äû¿¡ µû¶ó ÀÏÁ¤ÇÑ ¹üÀ§ ³»¿¡¼­ CustomizationÀÌ °¡´ÉÇÕ´Ï´Ù. ÀÚ¼¼ÇÑ »çÇ×Àº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.
¤± º¸°í¼­¿¡ µû¶ó ÃֽŠÁ¤º¸·Î ¾÷µ¥ÀÌÆ®ÇÏ¿© º¸³»µå¸³´Ï´Ù. ¹è¼Û±âÀÏÀº ¹®ÀÇÇØ Áֽñ⠹ٶø´Ï´Ù.

Çѱ۸ñÂ÷

´ÜÀÏ¿°±â´ÙÇü¼º(SNP) Áö³ëŸÀÌÇÎ ¹× ºÐ¼® ½ÃÀå ±Ô¸ð´Â ÇâÈÄ ¸î ³â µ¿¾È ¿¬Æò±Õ 20.6%ÀÇ ¼ºÀå·üÀ» ±â·ÏÇϸç 2029³â±îÁö 394¾ï 1,000¸¸ ´Þ·¯ ±Ô¸ð·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾ÈÀÇ ¼ºÀåÀº Áý´Ü À¯ÀüüÇÐ °³³äÀÇ È®´ë, Èñ±ÍÁúȯ Áø´Ü¿¡ ´ëÇÑ °­Á¶, µ¿¹ÝÁø´Ü ¹× Á¤¹Ð Á¾¾çÇÐÀÇ ºÎ»ó, DTC(Direct-to-Consumer) À¯ÀüüÇп¡ ´ëÇÑ ¼ö¿ä Áõ°¡, À¯Àüü ÀÇÇп¡ ´ëÇÑ ±ÔÁ¦ ´ç±¹ÀÇ Áö¿ø µî¿¡ ÀÇÇØ ÁÖµµµÉ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¿¹Ãø ±â°£ µ¿¾È ¿¹»óµÇ´Â ÁÖ¿ä µ¿ÇâÀ¸·Î´Â À¯Àüü ºÐ¼® ±â¼úÀÇ ¹ßÀü, ÀΰøÁö´É°ú »ý¹°Á¤º¸ÇÐÀÇ ÅëÇÕ, Á¾¾çÇÐ ¿¬±¸ÀÇ ¹ßÀü, ¹ýÀÇÇÐ ¹× °¡°è °Ë»ç¿¡¼­ÀÇ È°¿ëµµ Áõ°¡, ÈÞ´ë¿ë À¯Àüü ºÐ¼® ±â±â °³¹ß µîÀÌ ÀÖ½À´Ï´Ù.

À¯Àü¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ´ÜÀÏ¿°±â´ÙÇü¼º(SNP) Áö³ëŸÀÌÇÎ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. À¯Àü¼º ÁúȯÀº DNA ÀÌ»ó¿¡ ÀÇÇØ ¹ß»ýÇϸç, DNA ÀÌ»óÀº ÇÑÂÊ ºÎ¸ð·ÎºÎÅÍ ¹°·Á¹Þ°Å³ª ¼¼Æ÷ºÐ¿­ ½Ã µ¹¿¬º¯ÀÌ¿¡ ÀÇÇØ ¹ß»ýÇÕ´Ï´Ù. ÀνÄÀÌ ³ô¾ÆÁö°í Áø´Ü ±â¼úÀÌ Çâ»óµÊ¿¡ µû¶ó ´õ ¸¹Àº À¯Àü¼º ÁúȯÀÌ Àνĵǰí Áø´ÜµÇ¾î À¯Àü¼º ÁúȯÀÇ ºÎ´ã Áõ°¡¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ´ÜÀÏ¿°±â´ÙÇü¼º(SNP) Áö³ëŸÀÌÇÎÀº Áúº´ À§Çè, ÁøÇà, ¾à¹° ¹ÝÀÀ°ú °ü·ÃµÈ À¯ÀüÀû µ¹¿¬º¯À̸¦ È®ÀÎÇÏ¿© Á¶±â Áø´Ü ¹× ¸ÂÃã Ä¡·á¸¦ °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ÀÌ¿¡ Áß¿äÇÑ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ³¶Æ÷¼º ¼¶À¯Áõ È£ÁÖ°¡ 2024³â 2¿ù¿¡ ¹ßÇ¥ÇÑ º¸°í¼­¿¡ µû¸£¸é, È£ÁÖÀÇ ³¶Æ÷¼º ¼¶À¯Áõ ȯÀÚ ¼ö´Â 2021³â 3,616¸í¿¡¼­ 2022³â 3,738¸íÀ¸·Î Áõ°¡Çß½À´Ï´Ù. ÀÌ¿¡ µû¶ó À¯Àü¼º ÁúȯÀÇ ºÎ´ã Áõ°¡´Â ´ÜÀÏ¿°±â´ÙÇü¼º(SNP) Áö³ëŸÀÌÇÎ ½ÃÀåÀÇ ¼ºÀåÀ» °¡¼ÓÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

SNP À¯ÀüÇüÁú ºÐ¼® ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷µéÀº ³ó¾÷ ºÐÀÚ À°Á¾À» À§ÇÑ ´ë±Ô¸ð ·Î¿ìÆÐ½º ÀüÀå À¯Àüü ¿°±â¼­¿­ ºÐ¼®°ú °°Àº ÷´Ü ¼Ö·ç¼Ç °³¹ß¿¡ ÁÖ·ÂÇϰí ÀÖ½À´Ï´Ù. ³ó¾÷¿ë ÀüÀåÀ¯Àüü ½ÃÄö½ÌÀº ÀÛ¹°À̳ª °¡ÃàÀÇ ¿ÏÀüÇÑ À¯Àü ¹°ÁúÀ» ÇØµ¶ÇÏ¿© ¼öÈ®·®, ³»º´¼º, ȯ°æ ÀûÀÀ¼º µîÀÇ ÇüÁúÀ» °³¼±ÇÕ´Ï´Ù. ¿¹¸¦ µé¾î, 2024³â 6¿ù Áß±¹ »ý¸í°øÇÐ ±â¾÷ MGI Tech´Â ´ë±Ô¸ð ³ó¾÷¿ë ·Î¿ìÆÐ½º ÀüÀå À¯Àüü ½ÃÄö½ÌÀ» À§ÇÑ È¿À²ÀûÀÎ Àüü ¿öÅ©ÇÃ·Î¿ì ¼Ö·ç¼ÇÀ» ¹ßÇ¥Çß½À´Ï´Ù. ÀÌ ¼Ö·ç¼ÇÀº DNA ÃßÃâ, ¶óÀ̺귯¸® Áغñ, ½ÃÄö½Ì, SNP &&InDel Äݸµ µî ³ó¾÷ À̹èü Á¾ÀÇ ºÐÀÚ À°Á¾ À¯ÀüÇüÁú ºÐ¼®À» À§ÇØ ¼³°èµÇ¾úÀ¸¸ç, MGIÀÇ DNBSEQ-T7 ¹× DNBSEQ-G400 ½ÃÄö¼­¸¦ »ç¿ëÇÏ¿© Ãʰí󸮷® 󸮷®°ú À¯¿¬¼ºÀ» Á¦°øÇϰí, µÅÁö ÂüÁ¶ ÆÐ³Î ¹× µ¥ÀÌÅÍ ºÐ¼® ¼ÒÇÁÆ®¿þ¾î¸¦ »ç¿ëÇÏ¿© ¸ÂÃãÇü µ¥ÀÌÅͺ£À̽º¸¦ ¸¸µéÁö ¾Ê°íµµ À¯ÀüÇüÁúÀ» È¿À²ÀûÀ¸·Î ºÐ¼®ÇÒ ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ½ÃÀå Æ¯Â¡

Á¦3Àå ½ÃÀå µ¿Çâ°ú Àü·«

Á¦4Àå ½ÃÀå - ±Ý¸®, ÀÎÇ÷¹À̼Ç, ÁöÁ¤ÇÐ, ¹«¿ª ÀüÀï°ú °ü¼¼, ±×¸®°í ÄڷγªÀç³­°ú ȸº¹ÀÌ ½ÃÀå¿¡ ¹ÌÄ¡´Â ¿µÇâÀ» Æ÷ÇÔÇÑ °Å½Ã°æÁ¦ ½Ã³ª¸®¿À

Á¦5Àå ¼¼°èÀÇ ¼ºÀå ºÐ¼®°ú Àü·« ºÐ¼® ÇÁ·¹ÀÓ¿öÅ©

Á¦6Àå ½ÃÀå ¼¼ºÐÈ­

Á¦7Àå Áö¿ªº°/±¹°¡º° ºÐ¼®

Á¦8Àå ¾Æ½Ã¾ÆÅÂÆò¾ç ½ÃÀå

Á¦9Àå Áß±¹ ½ÃÀå

Á¦10Àå Àεµ ½ÃÀå

Á¦11Àå ÀϺ» ½ÃÀå

Á¦12Àå È£ÁÖ ½ÃÀå

Á¦13Àå Àεµ³×½Ã¾Æ ½ÃÀå

Á¦14Àå Çѱ¹ ½ÃÀå

Á¦15Àå ¼­À¯·´ ½ÃÀå

Á¦16Àå ¿µ±¹ ½ÃÀå

Á¦17Àå µ¶ÀÏ ½ÃÀå

Á¦18Àå ÇÁ¶û½º ½ÃÀå

Á¦19Àå ÀÌÅ»¸®¾Æ ½ÃÀå

Á¦20Àå ½ºÆäÀÎ ½ÃÀå

Á¦21Àå µ¿À¯·´ ½ÃÀå

Á¦22Àå ·¯½Ã¾Æ ½ÃÀå

Á¦23Àå ºÏ¹Ì ½ÃÀå

Á¦24Àå ¹Ì±¹ ½ÃÀå

Á¦25Àå ij³ª´Ù ½ÃÀå

Á¦26Àå ³²¹Ì ½ÃÀå

Á¦27Àå ºê¶óÁú ½ÃÀå

Á¦28Àå Áßµ¿ ½ÃÀå

Á¦29Àå ¾ÆÇÁ¸®Ä« ½ÃÀå

Á¦30Àå °æÀï ±¸µµ¿Í ±â¾÷ °³¿ä

Á¦31Àå ±âŸ ÁÖ¿ä ±â¾÷ ¹× Çõ½Å ±â¾÷

Á¦32Àå ¼¼°è ½ÃÀå °æÀï º¥Ä¡¸¶Å·°ú ´ë½Ãº¸µå

Á¦33Àå ÁÖ¿ä ÀμöÇÕº´(M&A)

Á¦34Àå ÃÖ±Ù ½ÃÀå µ¿Çâ

Á¦35Àå ½ÃÀå ÀáÀç·ÂÀÌ ³ôÀº ±¹°¡, ºÎ¹®, Àü·«

Á¦36Àå ºÎ·Ï

LSH
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

SNP genotyping and analysis involves detecting and studying single nucleotide polymorphisms (SNPs) variations at a single base pair in the genome across different individuals or populations. This is done using techniques such as PCR, microarrays, or sequencing. The process allows researchers to explore genetic diversity, track inheritance patterns, and gain insights into individual variations in drug responses or susceptibility to certain conditions.

The main sample types used in SNP genotyping and analysis include genomic DNA, RNA, cell-free DNA (cfDNA), plasma, and whole blood. Genomic DNA refers to the complete set of genetic material in an organism, which holds all the instructions needed for its growth and functioning. Various technologies are used to conduct the analysis, including microarrays, gene chips, TaqMan allelic discrimination, SNP pyrosequencing, Applied Biosciences SNPlex, and Sequenom MassArray MALDI-TOF. These methods serve different applications such as disease diagnostics, pharmacogenomics, precision medicine, forensic science, and agriculture. The target users for these technologies include hospitals, research labs, pharmaceutical and biotech companies, diagnostic labs, as well as academic and government institutions.

The SNP genotyping and analysis market research report is one of a series of new reports from The Business Research Company that provides SNP genotyping and analysis market statistics, including SNP genotyping and analysis industry global market size, regional shares, competitors with an SNP genotyping and analysis market share, detailed SNP genotyping and analysis market segments, market trends and opportunities, and any further data you may need to thrive in the SNP genotyping and analysis industry. This SNP genotyping and analysis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The SNP genotyping and analysis market size has grown rapidly in recent years. It will grow from $15.45 billion in 2024 to $18.65 billion in 2025 at a compound annual growth rate (CAGR) of 20.7%. The growth observed during the historical period can be credited to factors such as increased funding for biomedical research, the expansion of personalized medicine efforts, the rise of agricultural genomics, the high prevalence of chronic diseases, and the emergence of commercial genomic services.

The SNP genotyping and analysis market size is expected to see rapid growth in the next few years. It will grow to $39.41 billion in 2029 at a compound annual growth rate (CAGR) of 20.6%. The growth during the forecast period is expected to be driven by the expansion of population genomics initiatives, a stronger emphasis on diagnosing rare diseases, the rise in companion diagnostics and precision oncology, growing demand for direct-to-consumer (DTC) genomics, and regulatory support for genomic medicine. Key trends anticipated for the forecast period include advancements in genotyping technologies, the integration of artificial intelligence and bioinformatics, growth in oncology research, increased use in forensic and ancestry testing, and the development of portable genotyping devices.

The rising prevalence of genetic diseases is anticipated to drive the growth of the SNP genotyping and analysis market. Genetic diseases are caused by abnormalities in DNA, which may either be inherited from one or both parents or occur due to mutations during cell division. As awareness grows and diagnostic technologies improve, more genetic disorders are being recognized and diagnosed, contributing to the increasing burden of genetic diseases. SNP genotyping and analysis play a crucial role in this by identifying genetic variations linked to disease risk, progression, and drug responses, enabling early diagnosis and personalized treatment. For example, according to a report published by Cystic Fibrosis Australia in February 2024, the number of people living with cystic fibrosis in Australia increased to 3,738 in 2022, up from 3,616 in 2021. As a result, the growing burden of genetic diseases is expected to fuel the growth of the SNP genotyping and analysis market.

Leading companies in the SNP genotyping and analysis market are focusing on creating advanced solutions, such as large-scale low-pass whole genome sequencing for agricultural molecular breeding. Agricultural whole genome sequencing involves decoding the complete genetic material of crops or livestock to improve traits such as yield, disease resistance, and environmental adaptability. For instance, in June 2024, MGI Tech, a biotechnology company based in China, introduced an efficient whole workflow solution for large-scale agricultural low-pass whole genome sequencing. This solution, designed for molecular breeding genotyping of agricultural diploid species, includes DNA extraction, library preparation, sequencing, and SNP & InDel calling. It utilizes MGI's DNBSEQ-T7 and DNBSEQ-G400 sequencers, offering ultra-high throughput and flexibility, alongside pig reference panels and data analysis software to streamline genotyping without the need for custom database creation.

In January 2023, QIAGEN N.V., a Germany-based provider of sample and assay technologies, acquired Verogen, Inc. The acquisition aims to enhance QIAGEN's leadership in human identification and forensics by integrating Verogen's advanced NGS tools and bioinformatics solutions into its existing portfolio. Verogen, a U.S.-based biotechnology company, specializes in SNP genotyping and analysis, offering tools such as the Forenseq Kintelligence kit and universal analysis software for forensic applications.

Major players in the snp genotyping and analysis market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Eurofins Genomics Inc., Agilent Technologies Inc., Illumina Inc., PerkinElmer Inc., Beckman Coulter Life Sciences Inc., Bio-Rad Laboratories Inc., QIAGEN N.V., Natera Inc., Myriad Genetics Inc., Azenta Life Sciences Inc., LGC Limited, Invitae Corporation, Oxford Nanopore Technologies Limited, Standard BioTools Inc., Pacific Biosciences of California Inc., NanoString Technologies Inc., Sophia Genetics SA, Genedata AG, Genotypic Technology Private Limited, PREMIER Biosoft International.

North America was the largest region in the SNP genotyping and analysis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in SNP genotyping and analysis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the SNP genotyping and analysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The SNP genotyping and analysis market consists of revenues earned by entities by providing services such as DNA extraction and quality control, whole genome SNP analysis, SNP chip services, genetic association studies, and bioinformatics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. The SNP genotyping and analysis market also includes sales of genotyping platforms, genotyping assays/kits, bioinformatics software, Axiom genome-wide arrays, and bioinformatics analysis tools. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values and are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

SNP Genotyping And Analysis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on snp genotyping and analysis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for snp genotyping and analysis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The snp genotyping and analysis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Scope

Table of Contents

1. Executive Summary

2. SNP Genotyping And Analysis Market Characteristics

3. SNP Genotyping And Analysis Market Trends And Strategies

4. SNP Genotyping And Analysis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global SNP Genotyping And Analysis Growth Analysis And Strategic Analysis Framework

6. SNP Genotyping And Analysis Market Segmentation

7. SNP Genotyping And Analysis Market Regional And Country Analysis

8. Asia-Pacific SNP Genotyping And Analysis Market

9. China SNP Genotyping And Analysis Market

10. India SNP Genotyping And Analysis Market

11. Japan SNP Genotyping And Analysis Market

12. Australia SNP Genotyping And Analysis Market

13. Indonesia SNP Genotyping And Analysis Market

14. South Korea SNP Genotyping And Analysis Market

15. Western Europe SNP Genotyping And Analysis Market

16. UK SNP Genotyping And Analysis Market

17. Germany SNP Genotyping And Analysis Market

18. France SNP Genotyping And Analysis Market

19. Italy SNP Genotyping And Analysis Market

20. Spain SNP Genotyping And Analysis Market

21. Eastern Europe SNP Genotyping And Analysis Market

22. Russia SNP Genotyping And Analysis Market

23. North America SNP Genotyping And Analysis Market

24. USA SNP Genotyping And Analysis Market

25. Canada SNP Genotyping And Analysis Market

26. South America SNP Genotyping And Analysis Market

27. Brazil SNP Genotyping And Analysis Market

28. Middle East SNP Genotyping And Analysis Market

29. Africa SNP Genotyping And Analysis Market

30. SNP Genotyping And Analysis Market Competitive Landscape And Company Profiles

31. SNP Genotyping And Analysis Market Other Major And Innovative Companies

32. Global SNP Genotyping And Analysis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The SNP Genotyping And Analysis Market

34. Recent Developments In The SNP Genotyping And Analysis Market

35. SNP Genotyping And Analysis Market High Potential Countries, Segments and Strategies

36. Appendix

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â